Mild Alzheimer's patients benefit from 40Hz sensory stimulation in national clinical trial

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

At the Clinical Trials on Alzheimer's Disease conference in Boston Nov. 16, MIT spinoff company Cognito Therapeutics announced the results of its pivotal clinical trial of a noninvasive, device-based approach to Alzheimer's disease (AD) treatment first discovered in The Picower Institute in 2014. The "HOPE" trial included 663 people in two "prespecified" subgroups of volunteers: those with…

Read original article on Medical Xpress - latest medical and health news stories →